Diagnosed with Stage 2 non-small cell lung cancer upper lobe of left lung with one tumor and one lymph node.
Surgery on 10/23/14 wherein esophagus and right lung were first examined and biopsy done on lymph nodes showed negative cancer cells, proceeded to remove upper left lung lobe.
No remaining visible cancer yet Medical Oncologist wants me to have 4 sessions of chemo over next 3.5 months in case there are any remaining cancer cells.
I am 74 year old male and otherwise in good health and not convinced that chemo is a must? Would not CT or other method be used every 4-6 months to see if any cancer cells return? Not sure the quality of life is as good…
Dear NSCLC stage 2 patient-
Your question is a common one from early stage cancer patients who have undergone the “standard-of-care” for their cancer. You had surgery, and have been told “we got it all” so you are wondering what the risks and benefits are of more therapy.
According to the study linked and excerpted below, there is a good chance your non-small cell lung cancer will relapse. At the same time you will experience a lower quality of life if you undergo adjuvant chemotherapy. Translation, chemo will make you feel awful. And it may even cause permanent collateral damage.
What I think you are saying is, “do I really want to feel awful and risk collateral damage by undergoing more therapy?”
And the answer is up to you of course. Assume that there are “circulating stem cells” hiding in your system somewhere. CSC’s are the reason why most cancers recur.
Understand that there are evidence-based, non-toxic therapies to reduce your risk of lung cancer relapse.
I am a long-term survivor of an incurable cancer. I live in complete remission from my cancer by living an evidence-based, non-toxic lifestyle through nutrition, supplementation, bone health, etc. therapies.
If you would like to learn more about evidence-based, non-toxic lung cancer therapies scroll down the page, post a question or comment and I will reply to you ASAP.
“Surgery remains the initial treatment for patients with early-stage non-small cell lung cancer (NSCLC). The frequent occurrence of distant metastases and local regional failure after surgical resection would indicate that additional treatment is necessary. Early trials of adjuvant chemotherapy and postoperative radiation were often plagued by small patient sample size, inadequate surgical staging, and ineffective or antiquated treatment. A 1995 meta-analysis found a nonsignificant reduction in risk of death for postoperative cisplatin-based chemotherapy..
The primary importance of thoracic radiotherapy is in the reduction of local-regional relapse. In patients with stages I and II disease after adequate surgery the risk is low.…”
I am both a cancer survivor and cancer coach. If you would like to learn more about evidence-based, non-toxic therapies to reduce the risk of lung cancer, scroll down the page, post a question or comment and I will reply to you ASAP.